Li C, Wang X, Chen S
Xiyuan Hospital, China Academy of TCM, Beijing, China.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999 Apr;19(4):212-4.
To explore the effect of Qingkailing injection (QKLI) in treating acute fever.
Four hundred cases of acute upper respiratory tract infection were divided into three groups treated with QKLI 120 ml/d, 160 ml/d and 200 ml/d respectively, and compared with a control group treated with lincomycin 1.8 g/d.
The markedly effective rate of QKLI was 84.14% which was better than that of lincomycin (75.83%). The mean initial time of QKLI (12.6 h) was shorter than that of lincomycin (17.6 h). Effect of QKLI on patients with disease course within one day was better than that within 3 days. No significant difference revealed between effects in groups treated with different dosage of QKLI. The effect of QKLI in lowering white blood cell count was similar to that of lincomycin. For patients with positive throat swab culture of pathogenic bacteria, QKLI displayed good antibacterial action in vivo.
QKLI is a highly effective with rapid action drug for treatment of acute respiratory infection.
探讨清开灵注射液(QKLI)治疗急性发热的效果。
将400例急性上呼吸道感染患者分为三组,分别给予QKLI 120 ml/d、160 ml/d和200 ml/d进行治疗,并与给予林可霉素1.8 g/d的对照组进行比较。
QKLI的显效率为84.14%,优于林可霉素(75.83%)。QKLI的平均退热初时(12.6小时)短于林可霉素(17.6小时)。QKLI对病程在1天内的患者疗效优于病程在3天内的患者。不同剂量QKLI治疗组之间的疗效无显著差异。QKLI降低白细胞计数的作用与林可霉素相似。对于咽拭子病原菌培养阳性的患者,QKLI在体内显示出良好的抗菌作用。
QKLI是治疗急性呼吸道感染的高效速效药物。